Search results
PAXLOVID is a prescription treatment for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Feel sick? Connect to a doctor via telehealth. PAXLOVID is also authorized for certain people under an Emergency Use Authorization. Learn more. style. Gradient, center.
- Safety & Side Effects
PAXLOVID may lead to some HIV-1 medicines not working as...
- How to Take
Each pack contains several blister cards with your morning...
- Who Can Take
Including all of your prescription and over-the-counter...
- FAQs
Explore frequently asked questions about PAXLOVID™...
- Why Take Paxlovid
PAXLOVID reduced the risk of COVID‑19-related...
- How to Get Paxlovid
Work with your healthcare professional to get prescribed...
- Resources
These downloads and links can help you learn more about...
- Safety & Side Effects
Paxlovid is an antiviral medication used to treat COVID-19 to help decrease symptoms or avoid severe illness in certain patients. Paxlovid works by stopping the virus that causes COVID-19 (SARS-CoV-2) from multiplying. Paxlovid should be taken as soon as possible after diagnosis of COVID-19.
Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized.
The COVID-19 Treatment Guidelines Panel (the Panel) recommends using nirmatrelvir 300 mg with ritonavir 100 mg (Paxlovid) orally (PO) twice daily for 5 days in nonhospitalized adults with mild to moderate COVID-19 who are at high risk of disease progression (AIIa).
May 25, 2023. Español. Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment...
2024. Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19. Thursday, May 25, 2023 - 11:21am. View pdf copy Copy to clipboard Open in tab. PAXLOVID is the first FDA-approved oral treatment for COVID-19; has been authorized for emergency use since December 2021.
What is PAXLOVID? PAXLOVID is a medicine that is available under EUA for the treatment of mild-to-moderate COVID-19 in adults and children 12 years of age and older weighing at...
